Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Allogene Therapeutics Inc (ALLO)

Allogene Therapeutics Inc (ALLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Allogene Therapeutics Announces Presentation at 43rd Annual J.P. Morgan Healthcare Conference Quiver Quantitative, Inc. - Mon Dec 16, 5:56PM CST

Allogene Therapeutics announces CEO David Chang will present at the J.P. Morgan Healthcare Conference on January 15, 2025.Quiver AI SummaryAllogene Therapeutics, Inc., a clinical-stage biotechnology company...

ALLO : 1.8700 (+1.63%)
Allogene Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference GlobeNewswire - Mon Dec 16, 7:30AM CST

ALLO : 1.8700 (+1.63%)
Allogene Therapeutics Acknowledges the Passing of Founding Board Member David Bonderman GlobeNewswire - Thu Dec 12, 7:30AM CST

ALLO : 1.8700 (+1.63%)
Allogene Therapeutics Loses 23% Year to Date: How to Play the Stock?
Allogene Therapeutics Loses 23% Year to Date: How to Play the Stock? Zacks Investment Research - Mon Dec 2, 1:22PM CST

Shares of Allogene Therapeutics ALLO have lost nearly 23% year to date, underperforming the industry’s 7.0% decline. The stock has also underperformed the sector and the S&P 500 during the same period,...

ALLO : 1.8700 (+1.63%)
CSTL : 27.53 (+1.62%)
SPRO : 0.9551 (-4.30%)
Allogene Therapeutics Announces Participation in December Investor Conferences GlobeNewswire - Tue Nov 19, 7:30AM CST

ALLO : 1.8700 (+1.63%)
Allogene Therapeutics Announces Promising Preclinical Data for ALLO-329, an AlloCAR T™ Therapy Targeting Autoimmune Diseases Quiver Quantitative, Inc. - Mon Nov 18, 5:52PM CST

ALLO-329 shows promise in treating autoimmune diseases by targeting CD19+ B cells and CD70+ T cells without lymphodepletion.Quiver AI SummaryAllogene Therapeutics has announced promising preclinical data...

ALLO : 1.8700 (+1.63%)
Allogene Therapeutics Presents Preclinical Data for ALLO-329, an Allogeneic CD19/CD70 Dual CAR T for the Treatment of Autoimmune Disease at the American College of Rheumatology (ACR) Convergence GlobeNewswire - Mon Nov 18, 7:30AM CST

ALLO : 1.8700 (+1.63%)
Allogene Therapeutics: Q3 Earnings Snapshot AP - Thu Nov 7, 3:11PM CST

Allogene Therapeutics: Q3 Earnings Snapshot

ALLO : 1.8700 (+1.63%)
Allogene Therapeutics Reports Third Quarter 2024 Financial Results and Business Update GlobeNewswire - Thu Nov 7, 3:02PM CST

ALLO : 1.8700 (+1.63%)
Allogene Therapeutics Announces Positive Phase 1 Data Demonstrating the Potential of ALLO-316 in Heavily Pretreated Patients with Advanced Renal Cell Carcinoma at SITC and IKCS GlobeNewswire - Thu Nov 7, 9:00AM CST

ALLO : 1.8700 (+1.63%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot